TREATMENT WITH BISMUTE SUBCITRATE IN FRAGILE PATIENTS WITH SARS-CoV-2 INFECTION AND DIARRHEA NOT FITTING FOR TRANSFER TO ACUTE HOSPITAL (COVID-19) (COVID-19 BISMUTE)

First published 26/04/2020

Last updated 11/09/2024

EU PAS number:

EUPAS34925

Study

Planned

Documents

Study protocol

Initial protocol

Bismuth. English

English (132.1 KB - PDF)View document

Study results

Study report

Other information

Publications

Study publications

ENCePP Seal

This study has been awarded the ENCePP seal

ENCePP Seal documents

Conflicts of interest of investigators

conflict interest

English (76.28 KB - PDF)View document

Composition of steering group and observers

steering bismuth

English (65.17 KB - PDF)View document

Signed code of conduct

empty-file.pdf

English (14.94 KB - PDF)View document

Signed code of conduct checklist

empty-file.pdf

English (14.94 KB - PDF)View document

Signed checklist for study protocols

empty-file.pdf

English (14.94 KB - PDF)View document

Secondary tabs